Stock listing

Frankfurt:HBI0 Harvard Bioscience, Inc. Aktie

German listing (Frankfurt) of Harvard Bioscience, Inc. · home listing NASDAQ:HBIO

Follow Harvard Bioscience, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:HBIO

$8.66 USD -0.34 (-3.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:HBIO

Past year +54.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$8.53 – $9.00 USDNov 20, 2026
Volume
22,661 sharesNov 20, 2026
Market cap
$39.60M USDAt the close on Nov 20, 2026 · price × 4.57M shares outstanding
52-week range
$4.00 – $10.20 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$186,399 USDMedian day 16,561 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Harvard Bioscience, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HBIO · Home$8.66 USD-0.34 (-3.8%)22,661$8.58$9.00$8.53$9.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HBIO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$8.66-0.34-3.8%$8.58$9.00$8.5322,661
$9.00-0.08-0.9%$8.91$9.169$8.9118,914
$9.08+0.17+1.9%$9.00$9.58$8.82528,439
$8.91-0.48-5.1%$9.39$9.55$8.9121,638
$9.39+0.175+1.9%$9.50$9.67$9.36518,784
$9.215-0.465-4.8%$9.83$9.97$9.2115,565
$9.68+0.42+4.5%$9.46$10.20$9.30105,421
$9.26+0.17+1.9%$9.02$9.60$8.20888,184
$9.09+0.73+8.7%$8.44$9.32$8.3546,845
$8.36-0.10-1.2%$8.35$8.45$8.118,521
$8.46-0.15-1.7%$8.68$8.68$8.2174,071
$8.61-0.06-0.7%$8.85$8.85$8.5710,309
$8.67+0.07+0.8%$8.60$8.82$8.609,431
$8.60-0.30-3.4%$9.00$9.10$8.5728,611
$8.90+0.10+1.1%$8.80$8.92$8.7123,168
$8.80+0.38+4.5%$8.49$9.00$8.4949,996
$8.42+0.07+0.8%$8.35$8.48$8.3377,985
$8.35+0.03+0.4%$8.30$8.549$8.306,047
$8.32+0.09+1.1%$8.17$8.40$8.1724,337
$8.23-0.11-1.3%$8.13$8.40$8.1026,991
$8.34-0.15-1.8%$8.38$8.45$8.334,432
$8.49+0.15+1.8%$8.275$8.49$8.1511,429
$8.34+0.25+3.1%$7.90$8.38$7.9023,423
$8.090.000.0%$8.07$8.115$7.9112,593
$8.09-0.22-2.6%$8.22$8.35$7.9420,181
$8.31+0.16+2.0%$8.21$8.40$7.9516,561
$8.15-0.12-1.5%$8.12$8.37$7.9011,623
$8.27+0.03+0.4%$8.265$8.49$8.196,474
$8.240.000.0%$8.415$8.53$8.238,925
$8.24+0.11+1.4%$8.10$8.47$8.1012,404
$8.13-0.37-4.4%$8.47$8.80$7.9818,151
$8.50-0.06-0.7%$8.43$8.60$8.438,291
$8.56+0.06+0.7%$8.51$8.66$8.5110,301
$8.50+0.16+1.9%$8.44$8.80$8.4022,973
$8.34+0.21+2.6%$8.08$8.42$8.0315,471
$8.13+0.21+2.7%$7.90$8.13$7.8545,716
$7.92-0.04-0.5%$7.94$7.965$7.8515,104
$7.96-0.02-0.3%$8.00$8.066$7.88226,612
$7.98+0.02+0.3%$7.96$8.065$7.9232,313
$7.96-0.06-0.7%$8.02$8.05$7.925,398
$8.02-0.03-0.4%$8.02$8.13$7.9615,610
$8.05+0.13+1.6%$7.90$8.085$7.9023,233
$7.92-0.08-1.0%$8.02$8.09$7.9111,582
$8.00+0.05+0.6%$8.03$8.10$7.9020,019
$7.95-0.08-1.0%$8.00$8.19$7.9519,221
$8.03+0.06+0.8%$7.97$8.185$7.9712,122
$7.97-0.03-0.4%$7.99$8.09$7.959,077
$8.00-0.09-1.1%$8.07$8.075$7.9610,910
$8.09+0.06+0.7%$8.00$8.10$7.9639,265
$8.03-0.12-1.5%$8.18$8.18$8.0158,346
$8.15+0.20+2.5%$7.95$8.15$7.86815,710
$7.950.000.0%$7.94$8.043$7.919,094
$7.95-0.07-0.9%$7.90$8.15$7.8512,314
$8.02+0.02+0.2%$8.00$8.279$7.919,893
$8.00-0.20-2.4%$8.37$8.37$7.8524,493
$8.20+0.16+2.0%$8.05$8.40$7.8536,450
$8.04-0.07-0.9%$8.13$8.26$8.0021,033
$8.11+0.18+2.3%$7.92$8.12$7.9032,326
$7.93+0.03+0.4%$8.00$8.00$7.9120,639
$7.90+0.25+3.3%$7.67$7.90$7.6726,608
$7.65+0.07+0.9%$7.42$7.66$7.4210,539
$7.58+0.03+0.4%$7.36$7.58$7.366,055
$7.55+0.07+0.9%$7.45$7.579$7.36511,289
$7.48-0.07-0.9%$7.64$7.64$7.3710,660
$7.55+0.47+6.6%$6.94$7.63$6.9452,268

Splits

1 split · NASDAQ:HBIO · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
Frankfurt:HBI0
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Harvard Bioscience, Inc. news

Harvard Bioscience, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
16 in the last 12 months · 102 in all · newest Nov 10, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 10, 2026
Decks
44 decks · latest Nov 10, 2026

Where Harvard Bioscience, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HBIO · Home listingNASDAQUnited StatesUSD
BOATS:HBIOBOATSUnited StatesUSD
Frankfurt:HBI0 · This pageFrankfurtGermanyEUR
gettex:HBI0gettexGermanyEUR
Lang & Schwarz:A423J5Lang & SchwarzGermanyEUR
LS Exchange:A423J5LS ExchangeGermanyEUR
Munich:HBI0MunichGermanyEUR

Valuation

EV/sales 0.8× against a median of 1.2×: 5th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$71.90M USD
P/E
Loss
EV/sales
0.8×
EV/EBITDA
28.4×
Price/book
7.8×
Gross margin
57.4%
Operating margin
−1.8%
Net margin
−13.2%
Debt to equity
7.3×
Beta vs S&P 500
1.34

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Harvard Bioscience, Inc. · NASDAQ:HBIOUS$39.60MUS$71.90Mn/a0.8×28.4×7.8×−13.2%7.3×1.34
Labiana Health SA · BME:LABUS$44.35MUS$70.57M15.7×0.9×5.8×8.0×3.4%5.9×n/a
Access Bio, Inc. · KRX:950130US$44.14M−US$190.9Mn/a−10.8×n/a0.1×−468.1%0.0×n/a
EDX Medical Group plc · LSE:EDXUS$43.73MUS$39.92Mn/a92.3×n/a15.4×n/a0.0×n/a
Osang Healthcare Co. Ltd. · KRX:036220US$42.34MUS$24.17Mn/a0.3×n/a0.2×−8.8%0.1×n/a
ABL Diagnostics SA · EURONEXT:ABLDUS$41.27MUS$42.32M38.1×5.5×42.8×5.3×14.2%0.3×n/a
hVIVO plc · LSE:HVOUS$40.98MUS$42.20Mn/a0.7×7.5×1.0×−12.8%0.4×n/a
CytoGen, Inc. · KRX:217330US$38.57MUS$31.65Mn/a1.6×n/a1.6×−38.5%0.4×n/a
HUMASIS Co., Ltd. · KRX:205470US$37.47M−US$89.12Mn/a−3.8×n/a0.2×−49.2%0.0×n/a
IXICO PLC · LSE:IXIUS$37.24MUS$35.78Mn/a4.2×n/a2.7×−25.3%0.1×n/a
Mabion SA · GPW:MABUS$35.41MUS$41.97Mn/a9.7×n/a6.0×−321.4%1.3×n/a
Median of the othersUS$41.12MUS$37.85M26.9×1.2×7.5×2.1×−25.3%0.2×

Forecasts

1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
13.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.34 · 2 analysts
Revenue, year to Dec 2026
90.09M · 3 analysts

Team and board

OfficerRole
John DukePresident & Chief Executive Officer
Mark FrostChief Financial Officer and Treasurer
David PanzarellaSenior Vice President, Commercial
Diane HoustonVice President, Global IT
Lori PackerVice President, Global People Operations
Nitya ShettyVice President, Global Research and Development

Events

Calls

CallWhenStatus
Harvard Bioscience (NASDAQ:HBIO) Q3 2026 Earnings CallTue, Nov 10, 2026 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q2 2026 Earnings CallTue, Aug 11, 2026 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2026 Earnings CallTue, May 12, 2026 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q4 2025 Earnings CallThu, Mar 12, 2026 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2025 Earnings CallThu, Nov 06, 2025 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q2 2025 Earnings CallMon, Aug 11, 2025 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2025 Earnings CallMon, May 12, 2025 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q4 2024 Earnings CallWed, Mar 12, 2025 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2024 Earnings CallThu, Nov 07, 2024 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q2 2024 Earnings CallThu, Aug 08, 2024 · 10:00 AM ETReplay
All 25 calls
CallWhenStatus
Harvard Bioscience (NASDAQ:HBIO) Q1 2024 Earnings CallTue, May 07, 2024 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q4 2023 Earnings CallThu, Mar 07, 2024 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2023 Earnings CallTue, Apr 25, 2023 · 9:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q4 2022 Earnings CallThu, Mar 09, 2023 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2022 Earnings CallTue, Nov 08, 2022 · 5:30 PM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q2 2022 Earnings CallThu, Aug 04, 2022 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2022 Earnings CallWed, May 04, 2022 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q4 2021 Earnings CallTue, Mar 08, 2022 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2021 Earnings CallWed, Nov 03, 2021 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2021 Earnings CallThu, May 06, 2021 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q3 2020 Earnings CallThu, Nov 05, 2020Replay
Harvard Bioscience (NASDAQ:HBIO) Q2 2020 Earnings CallWed, Aug 05, 2020 · 8:00 AM ETReplay
Harvard Bioscience (NASDAQ:HBIO) Q1 2020 Earnings CallTue, May 05, 2020 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open+1.9%
Q2 2026Aug 11, 2026 · Before open−4.1%
Q1 2026May 12, 2026 · Before open−20.9%
Q4 2025Mar 5, 2026−4.1%
Q3 2025Nov 6, 2025 · Before open−7.3%
Q2 2025Aug 11, 2025 · Before open−9.3%
Q1 2025May 12, 2025 · Before open+11.8%
Q4 2024Mar 12, 2025−16.0%
Q3 2024Nov 7, 2024 · Before open−15.3%
Q2 2024Aug 8, 2024 · Before open+11.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · Before open−4.3%
Q4 2023Mar 7, 2024 · Before open+9.7%
Q3 2023Nov 7, 2023 · Before open−1.2%
Q2 2023Aug 8, 2023 · Before open−2.0%
Q1 2023Apr 25, 2023 · Before open+7.1%
Q4 2022Mar 9, 2023 · Before open+7.3%
Q3 2022Nov 8, 2022 · After close−9.5%
Q2 2022Aug 3, 2022 · After close−5.5%
Q1 2022May 4, 2022 · Before open−18.1%
Q4 2021Mar 8, 2022 · Before open+7.2%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings15 slidesNov 10, 2026
Investor Presentation (November 2026)Investor deck32 slidesNov 10, 2026
Q2 2026 Earnings PresentationEarnings15 slidesAug 11, 2026
Investor Presentation (August 2026)Investor deck32 slidesAugust 2026
Investor Presentation (May 2026)Investor deck31 slidesMay 12, 2026
Q1 2026 Earnings PresentationEarnings13 slidesMay 12, 2026
Q4 2025 Earnings PresentationEarnings14 slidesMar 12, 2026
Investor Presentation (March 2026)Investor deck30 slidesMarch 2026
Investor Presentation (January 2026)Investor deck15 slidesJanuary 2026
Q3 2025 Earnings PresentationEarnings11 slidesNov 6, 2025
All 44 decks
DeckKindSlidesDate
Q2 2025 Earnings PresentationEarnings12 slidesAug 11, 2025
Q1 2025 Earnings PresentationEarnings11 slidesMay 12, 2025
Q4 2024 Earnings PresentationEarnings12 slidesMar 12, 2025
Q3 2024 Earnings PresentationEarnings11 slidesNov 7, 2024
Sidoti Virtual Conference (September 2024)Conference17 slidesSep 18, 2024
Q2 2024 Earnings PresentationEarnings12 slidesAug 8, 2024
Q1 2024 Earnings PresentationEarnings12 slidesMay 7, 2024
Q4 2023 Earnings PresentationEarnings13 slidesMar 7, 2024
Investor Presentation (January 2024)Investor deck18 slidesJan 5, 2024
Investor Presentation (November 2023)Investor deck18 slidesNov 16, 2023
Q3 2023 Earnings PresentationEarnings12 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings12 slidesAug 8, 2023
Q1 2023 Earnings PresentationEarnings12 slidesApr 25, 2023
Q4 2022 Earnings PresentationEarnings12 slidesMar 9, 2023
Q3 2022 Earnings PresentationEarnings21 slidesNov 8, 2022
Q2 2022 Earnings PresentationEarnings21 slidesAug 4, 2022
Q1 2022 Earnings PresentationEarnings19 slidesMay 4, 2022
Q4 2021 Earnings PresentationEarnings21 slidesMar 8, 2022
Q3 2021 Earnings PresentationEarnings20 slidesNov 3, 2021
Q2 2021 Earnings PresentationEarnings20 slidesAug 5, 2021
Q1 2021 Earnings PresentationEarnings18 slidesMay 6, 2021
Q4 2020 Earnings PresentationEarnings18 slidesMar 10, 2021
Q3 2020 Earnings PresentationEarnings17 slidesNov 5, 2020
Q2 2020 Earnings PresentationEarnings18 slidesAug 5, 2020
Q1 2020 Earnings PresentationEarnings18 slidesMay 5, 2020
Q4 2019 Earnings PresentationEarnings22 slidesFeb 26, 2020
Q3 2019 Earnings PresentationEarnings15 slidesNov 5, 2019
Investor Presentation (September 2019)Investor deck29 slidesSeptember 2019
Investor Presentation (October 2018)Investor deck25 slidesOctober 2018
Investor Presentation (August 2012)Investor deck30 slidesAug 8, 2012
Investor Presentation (March 2009)Investor deck28 slidesMarch 2009
Investor Presentation (May 2007)Investor deck26 slidesMay 2007
Investor Presentation (August 2006)Investor deck27 slidesAugust 2006
Investor Presentation (June 2005)Investor deck36 slidesJun 1, 2005

Open Decks

Financings

RaiseDate
Senior secured term loans, including a convertible term loan, with warrants
Closed: US$40M raised · Warrants at US$0.5 · Guggenheim Securities
Dealers: Guggenheim Securities
Buyers: BroadOak Capital Partners ($40 million credit facility of three term loans, plus warrants for 2 million shares)
Use of proceeds: Retire existing debt obligations and associated fees, and strengthen balance sheet and capital structure
Dec 17, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue86.5M94.1M112.3M113.3M118.9M102.1M116.2M120.8M77.4M104.5M
Cost of revenue36.6M39.4M46.2M52.5M51.3M44.1M51.9M57.6M38.2M56.1M
Gross profit49.9M54.8M66.1M60.8M67.7M58.0M64.3M63.2M39.2M48.4M
Research and development8.82M10.4M11.8M12.3M10.8M8.69M10.7M11.0M5.64M5.39M
Selling, general and administrative17.7M21.5M22.8M24.5M24.3M23.5M22.8M21.4M18.6M20.9M
Operating income-48.6M-6.21M1.89M-6.93M2.07M221.0K377.0K984.0K-635.0K-3.00M
Depreciation and amortization1.74M1.73M1.47M1.45M1.78M1.92M1.99M2.42M1.32M1.53M
EBITDA-46.8M-4.48M3.37M-5.48M3.85M2.14M2.36M3.41M682.0K-1.47M
Interest expense1.30M800.0K3.59M2.55M1.54M4.83M5.41M5.37M713.0K639.0K
Income before tax-57.4M-11.7M-2.56M-9.18M-140.0K-7.29M-5.50M-7.97M-2.62M-3.08M
Income tax-686.0K740.0K859.0K337.0K148.0K518.0K-815.0K-3.68M-605.0K1.23M
Net income-56.7M-12.4M-3.42M-9.52M-288.0K-7.81M-4.69M-2.92M-865.0K-4.31M
Earnings per share, basic-1.28-0.28-0.08-0.23-0.01-0.20-0.12-0.08-0.02-0.13
Earnings per share, diluted-1.28-0.28-0.08-0.23-0.01-0.20-0.12-0.08-0.02-0.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents8.61M4.11M4.28M4.51M7.82M8.32M8.34M8.17M5.73M5.60M
Short-term investments00
Receivables16.0M14.9M16.1M16.7M21.8M17.8M20.7M21.5M13.4M15.7M
Inventory20.8M23.2M24.7M26.4M27.6M22.3M22.1M25.1M16.8M20.0M
Current assets48.2M45.1M49.0M51.1M61.6M51.7M53.6M57.8M47.5M45.5M
Property, plant and equipment4.79M5.11M3.98M3.37M3.42M3.96M4.78M5.90M3.74M4.30M
Goodwill9.56M56.3M57.1M56.3M57.7M58.6M57.4M57.3M36.3M38.0M
Total assets80.1M126.6M137.4M145.4M162.3M156.3M164.9M168.6M109.4M107.8M
Accounts payable3.65M4.79M5.55M6.45M4.91M5.97M5.34M7.36M4.41M6.20M
Current liabilities22.0M55.0M26.5M23.2M25.3M21.1M25.3M25.5M14.0M14.6M
Long-term debt35.9M030.7M43.0M45.1M46.3M46.9M54.8M8.98M11.4M
Total debt35.9M37.0M37.0M46.8M48.3M48.0M53.8M60.8M11.9M13.8M
Total liabilities66.3M63.3M64.3M73.1M78.9M79.6M83.2M85.9M28.5M35.6M
Shareholders' equity13.7M63.3M73.1M72.2M83.4M76.7M81.7M82.7M80.9M72.2M
Shares outstanding4.47M44.1M43.4M42.1M41.1M39.4M38.2M37.4M35.0M35.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations6.73M1.44M14.0M1.15M1.26M9.33M8.04M2.88M1.06M5.38M
Capital spending-1.26M-2.64M-1.79M-1.59M-1.20M-1.15M-1.22M-986.0K-890.0K-1.48M
Free cash flow5.47M-1.20M12.2M-438.0K67.0K8.18M6.83M1.90M167.0K3.90M
Cash from investing-1.86M-1.34M-1.80M-1.59M-1.34M-1.40M-229.0K-53.8M-917.0K-62.0K
Cash from financing-1.29M-131.0K-12.1M-2.84M-252.0K-7.97M-7.62M53.1M-1.79M-4.87M
Dividends paid-1.63M-200.0K-221.0K00
Share buybacks-577.0K-2.52M-1.63M-3.51M-1.14M-221.0K4.56M160.0K182.0K
Change in cash4.51M-175.0K-225.0K-3.31M-496.0K-18.0K162.0K2.44M137.0K-1.15M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
8-K · Current reportNov 10, 2026Current reportSEC
8-K · Current reportNov 10, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 22, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
8-K · Current reportAug 11, 2026Current reportSEC
8-K · Current reportAug 11, 2026ResultsSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 11, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
S-8 · Registration statement for employee plansJun 10, 2026Offer documentSEC
8-K · Current reportJun 2, 2026Management or board changeSEC
SD · Specialized disclosureMay 27, 2026ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 12, 2026Current reportSEC
8-K · Current reportMay 12, 2026ResultsSEC
DEFA14A · Additional proxy materialApr 21, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2026Meeting noticeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
4 · Change in ownershipMar 23, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMar 23, 2026Big-stake noticeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
8-K · Current reportMar 17, 2026Current reportSEC
10-K · Annual reportMar 13, 2026Annual reportSEC
8-K · Current reportMar 12, 2026ResultsSEC
8-K · Current reportMar 10, 2026Management or board changeSEC
8-K · Current reportMar 6, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2026Big-stake noticeSEC
8-K · Current reportFeb 10, 2026ResultsSEC
EFFECT · Notice that a registration is effectiveFeb 10, 2026Other filingsSEC
424B3 · ProspectusFeb 9, 2026Offer documentSEC
CORRESP · Letter to the SECFeb 5, 2026Other filingsSEC
UPLOAD · Letter from the SECFeb 5, 2026Other filingsSEC
DEF 14A · Proxy statementJan 30, 2026Meeting noticeSEC
S-3 · Registration statementJan 30, 2026Offer documentSEC
8-K · Current reportJan 29, 2026Current reportSEC
PRE 14A · Preliminary proxy statementJan 20, 2026Meeting noticeSEC
8-K · Current reportJan 20, 2026Current reportSEC
8-K · Current reportJan 12, 2026Current reportSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 30, 2025Insider tradeSEC
8-K · Current reportDec 17, 2025Material contractSEC
8-K · Current reportDec 5, 2025Current reportSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 3, 2025Big-stake noticeSEC
4 · Change in ownershipOct 7, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 7, 2025Insider tradeSEC
8-K · Current reportOct 3, 2025Current reportSEC
8-K · Current reportSep 9, 2025Management or board changeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
8-K · Current reportAug 13, 2025Management or board changeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
8-K · Current reportAug 11, 2025Material contractSEC
8-K · Current reportAug 11, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 7, 2025Big-stake noticeSEC
4 · Change in ownershipJul 25, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 25, 2025Insider tradeSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 18, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 17, 2025Big-stake noticeSEC
8-K · Current reportJul 17, 2025Management or board changeSEC
8-K/A · Current report, amendedJun 27, 2025Current reportSEC
8-K · Current reportJun 23, 2025Current reportSEC
8-K · Current reportJun 13, 2025Management or board changeSEC
3 · Initial statement of ownershipJun 9, 2025Insider tradeSEC
8-K · Current reportJun 2, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 30, 2025Big-stake noticeSEC
SD · Specialized disclosureMay 27, 2025ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 14, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2025Quarterly reportSEC
8-K · Current reportMay 12, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 8, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 22, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 21, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2025Meeting noticeSEC
8-K · Current reportApr 16, 2025Management or board changeSEC
8-K · Current reportApr 10, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 8, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 7, 2025Big-stake noticeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMar 17, 2025Big-stake noticeSEC
10-K · Annual reportMar 13, 2025Annual reportSEC
8-K · Current reportMar 12, 2025ResultsSEC
8-K · Current reportMar 11, 2025Material contractSEC
SCHEDULE 13G · Big-stake noticeFeb 10, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 4, 2025Big-stake noticeSEC
4 · Change in ownershipJan 3, 2025Insider tradeSEC
4 · Change in ownershipDec 31, 2024Insider tradeSEC
4 · Change in ownershipDec 31, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 30, 2024Other filingsSEC
CORRESP · Letter to the SECDec 26, 2024Other filingsSEC
UPLOAD · Letter from the SECDec 12, 2024Other filingsSEC
S-3 · Registration statementDec 6, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
4 · Change in ownershipJun 14, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
SD · Specialized disclosureMay 29, 2024ESG reportSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
8-K · Current reportMay 14, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
ARS · Annual report to shareholdersApr 3, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 3, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 3, 2024Meeting noticeSEC
8-K · Current reportApr 3, 2024Material contractSEC
8-K · Current reportMar 26, 2024Management or board changeSEC
SC 13G · Big-stake noticeMar 19, 2024Big-stake noticeSEC
10-K · Annual reportMar 7, 2024Annual reportSEC
4 · Change in ownershipMar 7, 2024Insider tradeSEC
4 · Change in ownershipMar 7, 2024Insider tradeSEC
8-K · Current reportMar 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 26, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 22, 2024Big-stake noticeSEC
8-K · Current reportJan 5, 2024ResultsSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
10-Q · Quarterly reportNov 7, 2023Quarterly reportSEC
8-K · Current reportNov 7, 2023ResultsSEC
SC 13G · Big-stake noticeAug 28, 2023Big-stake noticeSEC
4 · Change in ownershipAug 21, 2023Insider tradeSEC
UPLOAD · Letter from the SECAug 16, 2023Other filingsSEC
CORRESP · Letter to the SECAug 9, 2023Other filingsSEC
10-Q · Quarterly reportAug 8, 2023Quarterly reportSEC
8-K · Current reportAug 8, 2023ResultsSEC
UPLOAD · Letter from the SECJul 28, 2023Other filingsSEC
8-K · Current reportJun 20, 2023Management or board changeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
SD · Specialized disclosureMay 30, 2023ESG reportSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
8-K · Current reportMay 15, 2023Meeting outcomeSEC
10-Q · Quarterly reportApr 26, 2023Quarterly reportSEC
8-K · Current reportApr 25, 2023ResultsSEC
ARS · Annual report to shareholdersApr 7, 2023Annual reportSEC
DEF 14A · Proxy statementApr 5, 2023Meeting noticeSEC
4 · Change in ownershipMar 16, 2023Insider tradeSEC
4 · Change in ownershipMar 15, 2023Insider tradeSEC
8-K · Current reportMar 13, 2023Current reportSEC
8-K · Current reportMar 10, 2023Management or board changeSEC
10-K · Annual reportMar 9, 2023Annual reportSEC
8-K · Current reportMar 9, 2023ResultsSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
4 · Change in ownershipMar 8, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 16, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 15, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
8-K · Current reportJan 19, 2023Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJan 11, 2023Big-stake noticeSEC
3 · Initial statement of ownershipJan 3, 2023Insider tradeSEC
4 · Change in ownershipJan 3, 2023Insider tradeSEC
4 · Change in ownershipJan 3, 2023Insider tradeSEC
8-K/A · Current report, amendedJan 3, 2023Management or board changeSEC
SC 13G · Big-stake noticeDec 21, 2022Big-stake noticeSEC
8-K · Current reportDec 12, 2022Management or board changeSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
10-Q · Quarterly reportNov 8, 2022Quarterly reportSEC
8-K · Current reportNov 8, 2022ResultsSEC
4 · Change in ownershipSep 15, 2022Insider tradeSEC
4 · Change in ownershipAug 29, 2022Insider tradeSEC
4 · Change in ownershipAug 26, 2022Insider tradeSEC
4 · Change in ownershipAug 24, 2022Insider tradeSEC
4 · Change in ownershipAug 22, 2022Insider tradeSEC
4 · Change in ownershipAug 18, 2022Insider tradeSEC
10-Q · Quarterly reportAug 4, 2022Quarterly reportSEC
8-K · Current reportAug 4, 2022ResultsSEC
4 · Change in ownershipJul 20, 2022Insider tradeSEC
4 · Change in ownershipJul 12, 2022Insider tradeSEC
SC 13G · Big-stake noticeJul 8, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeJun 21, 2022Big-stake noticeSEC
4 · Change in ownershipJun 17, 2022Insider tradeSEC
4 · Change in ownershipJun 14, 2022Insider tradeSEC
4 · Change in ownershipJun 14, 2022Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Harvard Bioscience, Inc.’s releases · as of Nov 3, 2026

Common shares
4,573,080
Fully diluted
4,573,080

Fully diluted

LineSharesAs of
Common shares4,573,080Nov 3, 2026

Warrants and options

Lot
Warrants · US$0.50 · expiry not stated

Share count over time

CountShares
Nov 3, 20264,573,080

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Weber Capital Management LLC300K6.6%US$2.37MSep 30, 2026
Vanguard201K4.4%US$1.59MSep 30, 2026
Acadian Asset Management LLC180K3.9%US$1.42MSep 30, 2026
Mink Brook Asset Management LLC124K2.7%US$984KSep 30, 2026
Corsair Capital Management, L.P.123K2.7%US$973KSep 30, 2026
Renaissance Technologies94,3272.1%US$747KSep 30, 2026
Two Sigma85,5351.9%US$677KSep 30, 2026
BlackRock61,8931.4%US$490KSep 30, 2026
Geode Capital46,7531.0%US$370KSep 30, 2026
Millennium27,0600.59%US$214KSep 30, 2026
All 29 holders
HolderSharesOf the companyValueAs of
Essex Investment Management Co LLC26,9730.59%US$214KSep 30, 2026
Citadel24,8110.54%US$197KSep 30, 2026
Williams & Novak Wealth Management, LLC16,5550.36%US$131KSep 30, 2026
RBF Capital, LLC16,0000.35%US$127KSep 30, 2026
State Street14,9320.33%US$118KSep 30, 2026
UBS12,4040.27%US$98,240Sep 30, 2026
Gsa Capital Partners LLP11,4990.25%US$91,000Sep 30, 2026
Dimensional10,7530.24%US$85,164Sep 30, 2026
BNY10,2300.22%US$81,021Sep 30, 2026
Morgan Stanley9,9090.22%US$78,479Sep 30, 2026
Fidelity3,0860.07%US$24,441Sep 30, 2026
SBI Securities Co., Ltd.8660.02%US$6,859Sep 30, 2026
Brown Shipley& Co Ltd4780.01%US$3,786Sep 30, 2026
Tower Research Capital LLC (TRC)451<0.01%US$3,572Sep 30, 2026
Nisa Investment Advisors, LLC228<0.01%US$1,806Sep 30, 2026
RBC129<0.01%US$1,000Sep 30, 2026
BNP Paribas66<0.01%US$523Sep 30, 2026
JPMorgan32<0.01%US$255Sep 30, 2026
SHP Wealth Management10<0.01%US$62Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund123K2.7%US$759KJun 30, 2026
Vanguard Extended Market Index Fund42,0430.92%US$259KJun 30, 2026
Fidelity Extended Market Index Fund27,7690.61%US$163KMay 31, 2026
Acuitas US Microcap Fund13,3800.29%US$82,287Jun 30, 2026
Fidelity Total Market Index Fund7,0170.15%US$41,260May 31, 2026
Fidelity Series Total Market Index Fund5,9460.13%US$34,962May 31, 2026
Vanguard Balanced Index Fund4,1120.09%US$25,289Jun 30, 2026
Gabelli Global Mini Mites Fund4,0000.09%US$24,600Jun 30, 2026
Fidelity Nasdaq Composite Index Fund2,9360.06%US$17,264May 31, 2026
Dimensional US Sustainability Core 1 ETF1,9020.04%US$11,602Jul 31, 2026
All 19 holders
HolderSharesOf the companyValueAs of
Dimensional U.S. Small Cap ETF1,3660.03%US$8,333Jul 31, 2026
U.S. Vector Equity Portfolio1,2290.03%US$7,497Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF1,0290.02%US$6,277Jul 31, 2026
Dimensional US Core Equity 1 ETF9280.02%US$5,661Jul 31, 2026
Blackstone Alternative Multi-Strategy Fund6830.01%US$4,200Jun 30, 2026
LVIP Dimensional U.S. Core Equity 2 Fund6010.01%US$3,696Jun 30, 2026
U.S. Small Cap Portfolio258<0.01%US$1,574Jul 31, 2026
BlackRock Advantage Small Cap Core Fund30<0.01%US$176May 29, 2026
U.S. Sustainability Core 1 Portfolio24<0.01%US$146Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Frost Mark T
Officer: Chief Financial Officer
Buy5,000USD 5.00US$25,000Mar 16, 2026

Big stakes

StakeStakeSharesDateFiling
William Snider15.97%846KDec 17, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Gagnon
Other companies: Purple Biotech Ltd. (Board Member · Since at least Mar 18, 2026); Opus Genetics, Inc. (Chief Financial Officer · Since at least Sep 2, 2025); Bone Biologics Corp (Director · Since at least Jan 8, 2024); Verastem, Inc. (Director · Since at least Aug 28, 2018); Clean Harbors, Inc. (EVP CFO and Treasurer · Aug 20, 2012 – Sep 11, 2012 · Past); Biogen Inc. (Vice President, Finance · Nov 3, 2010 – Feb 28, 2012 · Past)
Director · Since at least Nov 18, 2013
Bertrand Loy
Other companies: ITT Inc. (Director · Since at least Jun 29, 2026); Ashland Inc. (Director · Since at least May 15, 2026); Entegris, Inc. (Executive Chair, Director · Since at least Dec 1, 2010); BTU International Inc (Director · Jun 7, 2010 – Jan 30, 2015 · Past)
Director · Nov 6, 2014 – May 21, 2024 · Past
Mark Frost
Other companies: Fathom Digital Manufacturing Corp (Chief Financial Officer, Director · Feb 25, 2022 – Apr 4, 2024 · Past); Analogic Corporation (SVP, CFO & Treasurer · Nov 30, 2015 – Dec 5, 2016 · Past); AngioDynamics, Inc. (EVP and CFO · Nov 30, 2012 – Aug 6, 2015 · Past); Albany Molecular Research Inc (Chief Financial Officer · May 5, 2006 – Sep 14, 2012 · Past)
Chief Financial Officer and Treasurer · Since at least May 12, 2025
Alan Edrick
Other companies: OSI Systems, Inc. (Executive Vice President and Chief Financial Officer · Since at least Jun 30, 2022)
Director · May 24, 2022 – May 21, 2024 · Past
David Green
Other companies: Harvard Apparatus Regenerative Technology Inc (Director · Since at least Oct 16, 2013)
Director · Mar 22, 2006 – Feb 7, 2017 · Past
James W Green
Other companies: OSI Systems, Inc. (Pres., Spacelabs Healthcare · Jul 5, 2019 – Jul 5, 2019 · Past)
Director · Since at least May 23, 2019
Kamalam Unninayar
Other companies: Tetraphase Pharmaceuticals Inc (Chief Financial Officer · Oct 16, 2017 – Jan 17, 2018 · Past)
Chief Financial Officer · Nov 26, 2018 – Mar 7, 2019 · Past
Katherine A Eade
Other companies: Vaxxinity, Inc. (Director · Feb 1, 2023 – Jun 20, 2023 · Past)
Director · Since at least Oct 24, 2017
Michael A Rossi
Other companies: LENSAR, Inc. (Interim CFO · Since at least May 29, 2026)
Chief Financial Officer · Jul 18, 2019 – Dec 29, 2022 · Past
Susan M Steele
Other companies: Hill International Inc (Director · Jun 11, 2019 – Dec 27, 2022 · Past)
Director · Apr 6, 2020 – Jan 4, 2021 · Past
All 29 people
PersonSeat
William Snider
Other companies: Telesis Bio, Inc. (Director · Jun 5, 2023 – Jun 5, 2023 · Past)
Director · Since at least Dec 17, 2025
Bryce Anthony ChicoyneChief Financial Officer · Aug 9, 2006 – May 1, 2007 · Past
David PanzarellaSenior Vice President, Commercial · Since at least Nov 5, 2026
Diane HoustonVice President, Global IT · Since at least Nov 5, 2026
George UvegesDirector · Mar 17, 2006 – Mar 7, 2018 · Past
Jeffrey DucheminChief Executive Officer, Director · Aug 26, 2013 – Jul 7, 2019 · Past
Jennifer CoteChief Financial Officer · Jan 1, 2023 – Mar 19, 2025 · Past
John DukeChief Executive Officer, Director · Since at least Jun 2, 2025
Kenneth Fletcher OlsonChief Operating Officer · Nov 1, 2020 – Dec 29, 2021 · Past
Lori PackerVice President, Global People Operations · Since at least Nov 5, 2026
Neal J HarteDirector · May 25, 2006 – May 25, 2016 · Past
Nitya ShettyVice President, Global Research and Development · Since at least Nov 5, 2026
Robert A DishmanDirector · Jun 4, 2012 – Apr 28, 2015 · Past
Seth Benjamin BensonDirector · Since at least Jul 16, 2025
Stephen J DenelskyDirector · Since at least Sep 5, 2025
Susan M LuscinskiChief Operating Officer · Aug 9, 2006 – Nov 1, 2013 · Past
Thomas W LoewaldDirector · Oct 24, 2017 – May 21, 2024 · Past
Yoav SibonyVP - Global Sales · Oct 21, 2013 – Aug 3, 2015 · Past
Yong SunVP - Commercial Operations · Oct 28, 2013 – Jan 1, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Harvard Bioscience, Inc.